Outcome of AGM
Nectar Lifesciences Ltd has informed BSE that the 21st Annual General Meeting (AGM) of the Company was held on September 30, 2016.30-09-2016
30-09-2016
Fixes Book Closure for Final Dividend & AGM (e-voting)
Nectar Lifesciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2016 to September 30, 2016 (both days inclusive) for the purpose of Payment of Final Dividend & 21st Annual General Meeting (AGM) of the Company to be held on September 30, 2016.23-08-2016
Nectar Lifesciences Q1 net dips 16% to Rs 12.30 crore
Shares of Nectar Lifesciences closed 1.58 per cent down at Rs 34.35 on BSE23-08-2016
Standalone Financial Results, Limited Review Report for June 30, 2016
Nectar Lifesciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 201623-08-2016
Board Meeting on August 23, 2016
Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 23, 2016, inter alia, to consider and approve:1. The Unaudited Financial Results of the Company for the Quarter ended on June 30, 2016.2. To convene the Annual General Meeting of Members of the Company for the Financial Year 2015-16 and matters related thereto....13-08-2016
Shareholding for the Period Ended June 30, 2016
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here12-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Nectar Lifesciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.12-07-2016
Standalone & Consolidated Financial Results, Auditors Report for March 31, 2016
Nectar Lifesciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 20164. Consolidated Auditors Report for the period ended March 31, 20165. Declaration regarding Audit Report with unmodified opinion30-05-2016
Board recommends Final Dividend
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016 have recommended the 10% Final Dividend i.e. Re. 0.10/- per equity share to the members of the Company, out of profits of the Company for the financial year 2015-2016, subject to the approval of the members in their Annual General Meeting.30-05-2016